Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models von Ma, Brigette B.Y, Lui, Vivian W.Y, Hui, Connie W.C, Lau, Cecilia P.Y, Wong, Chi H, Hui, Edwin P, Ng, Margaret H.L, Cheng, Suk H, Tsao, Sai W, Tsang, Chi-Man, Cheung, Crystal S.F, Ho, Kakiu, Chan, Anthony T.C

Volltext

A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) von Hui, Edwin Pun, Ma, Brigette, Mo, Frankie, Kam, Michael KM, Chan, Stephen Lam, Loong, Herbert H. F., Ho, Rosalie, Leung, Sing Fai, King, Ann Dorothy, Wang, Ki, Ahuja, Anil Tejbhan, Chan, Charles, Hui, Connie WC, Wong, Chi Hang, Chan, Anthony T. C.

Volltext

Abstract 1373: Preclinical activity of axitinib and its associated change of serum biomarkers in nasopharyngeal carcinoma (NPC) von Hui, Edwin Pun, Lui, Vivian WY, Hui, Connie WC, Lau, Cecilia PY, Loong, Herbert HF, Wong, Cesar SC, Wong, Eric CH, Chan, Anthony TC

Volltext